Butyrylcholinesterase Expression in Plants

Award Notice Posted

Solicitation number
DARPA-BAA-12-31
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

3 versions

Update #3 · Latest ·

Please see Attached Modification P00002 which extends the Full Proposal due date.

Update #2 ·

Modification 1 to DARPA-BAA-12-31 is to revise DARPA's mailing address. See attached modification for details.

Update #1 ·

DARPA is seeking innovative research proposals that will demonstrate the ability to produce a recombinant butyrylcholinesterase (rBuChE) using the Nicotiana benthamiana plant-based expression platform that has the same pharmacokinetic profile as a plasma-derived human butyrylcholinesterase (hBuChE) butyrylcholinesterase. The funding is intended to establish the technical precedence for the use of the plant platform to generate a rapid and scalable form of pre-exposure therapeutic bioscavenger against organophosphate nerve agents. Funding is for basic research only. The anticipated period of funding is for 12 months.

See attached DARPA-BAA-12-31.

Files

File Type Posted
DARPA-BAA-12-31 Modification 2.pdf PDF
DARPA-BAA-12-31 Modification 1.pdf PDF
DARPA-BAA-12-31.pdf PDF

Notice history

Notice Type Posted
Butyrylcholinesterase Expression in Plants. Latest Award Notice
Butyrylcholinesterase Expression in Plants Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity